Clinical trial
The Pharmacogenomics of Paclitaxel in Patients With Ovarian Cancer: Predictors of Toxicity and Response
NCT00415181 is registered in ClinicalTrials.gov with University of Southern Denmark as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Pharmacogenomics of Paclitaxel in Patients With Ovarian Cancer: Predictors of Toxicity and Response
- Lead sponsor
- University of Southern Denmark
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2006
- Completion date
- March 31, 2013
- Enrollment
- 93 (actual)
- Sites
- 4
Conditions
As the registry lists them; a condition with its own page is linked.